FIELD: pharmaceutical chemistry. SUBSTANCE: method involves utilization of timorol, betaxolol, carteolol, methypranolol, carbopol, and preservative, e.g., ethylenediaminetetraacetic acid, benzylconium chloride, and centrimed. 0.5% timolol gel prepared according to invention was tested on normal eyes as well as on glaucoma-damaged eyes. EFFECT: increased by about 15% reduction of intraocular pressure both on normal and glaucoma-damaged eyes. 6 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG FOR TREATING AND PREVENTING HIGH INTRAOCULAR PRESSURE | 2018 |
|
RU2693899C1 |
| INTRAOCULAR SYSTEMS OF SUSTAINED-RELEASE DRUG DELIVERY AND METHOD OF TREATING OPHTHALMIC DISEASES | 2010 |
|
RU2532333C2 |
| DROPS FOR TREATING OCULAR HYPERTENSION AND GLAUCOMA, AND METHOD FOR PREPARING SAID DROPS | 1995 |
|
RU2099049C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF GEL-LIKE OPHTHALMIC DROPS FOR TREATING GLAUCOMA | 2015 |
|
RU2576778C1 |
| OPHTHALMIC COMPOSITION BASED ON AQUEOUS SOLUTION OF ION- SENSITIVE HYDROPHILIC POLYMER (VARIANTS) | 1995 |
|
RU2139016C1 |
| METHOD OF TREATING PRIMARY GLAUCOMA IN PATIENTS WITH ACCOMPANYING ARTERIAL HYPERTENSION | 2015 |
|
RU2607291C1 |
| ANTIGLAUCOMATOUS AGENT | 1997 |
|
RU2128486C1 |
| BIMATOPROST AND THYMOLOL SOLUTIONS NOT CONTAINING CONSERVANTS | 2011 |
|
RU2624534C2 |
| LOW-DOSE BRIMONIDINE COMBINATIONS AND THEIR USE | 2018 |
|
RU2801221C2 |
| INHIBITORS OF HYSTONE DEACETYLASE FOR TREATMENT OF DEGENERATIVE EYE DISEASES | 2003 |
|
RU2324483C2 |
